Skip to main content

Table 2 Plasma levels of proinflammatory cytokines and ceramide molecules

From: Ceramides and pro-inflammatory cytokines for the prediction of acute coronary syndrome: a multi-marker approach

Variables

total(n = 216)

ACS(n = 138)

non ACS(n = 78)

P

TNF-α(pg/mL)

11.75 ± 8.78

13.04 ± 9.21

9.47 ± 7.47

0.004

IL-6(pg/mL)

7.59 ± 5.36

9.09 ± 5.70

5.93 ± 3.99

0.000

IL-8(pg/mL)

24.08 ± 14.14

24.45 ± 13.65

23.41 ± 15.04

0.604

Cer (d18:1/16:0)(µmol/L)

155.17 ± 48.11

165.00 ± 49.09

137.79 ± 41.20

0.000

Cer (d18:1/18:0)(µmol/L)

44.75 ± 18.85

46.71 ± 18.81

41.28 ± 18.54

0.042

Cer (d18:1/24:0)(µmol/L)

1835.10 ± 6761.38

1933.30 ± 710.43

1661.36 ± 559.21

0.004

Cer (d18:1/24:1)(µmol/L)

486.19 ± 193.99

495.28 ± 180.50

470.10 ± 216.09

0.361

Cer (d18:1/14:0)(µmol/L)

2.68 ± 1.36

2.80 ± 1.43

2.48 ± 1.21

0.097

Cer (d18:1/20:0)(µmol/L)

54.10 ± 20.53

56.27 ± 21.37

50.25 ± 18.45

0.038

Cer (d18:1/22:0)(µmol/L)

421.32 ± 159.87

442.57 ± 174.76

383.72 ± 121.56

0.009

  1. Continuous variables are presented as mean value ± 1 SD.
  2. TNF-α, tumor necrosis α; IL-6,interleukin-6;IL-8,interleukin-8;Cer, ceramide